| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.172 | 48.620 | 47.029 | 57.140 | 48.613 | 57.738 | 95.062 | 67.420 | 81.303 | 69.045 |
| Total Income - EUR | 49.175 | 48.622 | 47.032 | 57.145 | 48.622 | 58.586 | 95.084 | 67.459 | 81.334 | 92.025 |
| Total Expenses - EUR | 32.715 | 42.164 | 42.232 | 45.989 | 48.007 | 42.707 | 43.532 | 61.449 | 54.815 | 119.653 |
| Gross Profit/Loss - EUR | 16.460 | 6.458 | 4.800 | 11.157 | 615 | 15.879 | 51.552 | 6.010 | 26.519 | -27.628 |
| Net Profit/Loss - EUR | 14.985 | 5.558 | 4.329 | 10.585 | 129 | 15.301 | 50.600 | 5.335 | 25.706 | -30.395 |
| Employees | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 4 |
Check the financial reports for the company - Zomtravetmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 648 | 1.305 | 1.283 | 0 | 0 | 0 | 0 | 23.352 | 17.208 | 0 |
| Current Assets | 24.135 | 18.476 | 12.487 | 23.682 | 29.215 | 30.717 | 75.011 | 41.440 | 40.957 | 66.078 |
| Inventories | 1.337 | 5.169 | 3.512 | 3.012 | 3.561 | 2.590 | 2.544 | 3.039 | 1.142 | 1.623 |
| Receivables | 12.016 | 7.574 | -574 | 14.397 | 7.107 | 3.489 | 29.566 | 27.323 | 21.964 | 18.401 |
| Cash | 10.782 | 5.733 | 9.549 | 6.273 | 18.547 | 24.638 | 42.901 | 11.079 | 17.851 | 46.054 |
| Shareholders Funds | 20.857 | 15.068 | 4.390 | 10.644 | 10.567 | 25.668 | 70.180 | 5.391 | 27.078 | -3.468 |
| Social Capital | 52 | 51 | 50 | 49 | 48 | 48 | 46 | 47 | 46 | 46 |
| Debts | 3.926 | 4.713 | 9.380 | 13.038 | 18.648 | 5.049 | 4.831 | 59.401 | 31.087 | 69.546 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Zomtravetmed S.r.l.